Literature DB >> 25035645

Adenocarcinoma of esophagogastric junction: controversial classification, surgical management, and clinicopathology.

Lei Huang1, A-Man Xu1.   

Abstract

Entities:  

Year:  2014        PMID： 25035645      PMCID： PMC4076717          DOI： 10.3978/j.issn.1000-9604.2014.06.14

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  19 in total

1.  Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.

Authors:  Yun-Suhk Suh; Dong-Seok Han; Seong-Ho Kong; Hyuk-Joon Lee; Young Tae Kim; Woo-Ho Kim; Kuhn Uk Lee; Han-Kwang Yang
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

2.  The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.

Authors:  Elizabeth G Demicco; Alton B Farris; Yoshifumi Baba; Brian Agbor-Etang; Kristin Bergethon; Rajni Mandal; Diane Daives; Junya Fukuoka; Michio Shimizu; Dora Dias-Santagata; Shuji Ogino; A John Iafrate; Henning A Gaissert; Mari Mino-Kenudson
Journal:  Mod Pathol       Date:  2011-05-13       Impact factor: 7.842

3.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

4.  Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.

Authors:  Hiroharu Yamashita; Hitoshi Katai; Shinji Morita; Makoto Saka; Hirokazu Taniguchi; Takeo Fukagawa
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

5.  Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery : early results and toxicity.

Authors:  Bernhard J Leibl; Stephanie Vitz; Wolfgang Schäfer; Martin Alfrink; Andreas Gschwendtner; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2011-03-24       Impact factor: 3.621

6.  Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction.

Authors:  Masayoshi Yamada; Ichiro Oda; Satoru Nonaka; Haruhisha Suzuki; Shigetaka Yoshinaga; Hirokazu Taniguchi; Shigeki Sekine; Ryoji Kushima; Yutaka Saito; Takuji Gotoda
Journal:  Endoscopy       Date:  2013-11-28       Impact factor: 10.093

7.  Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.

Authors:  Hyoung-Il Kim; Jae-Ho Cheong; Ki Jun Song; Ji Yeong An; Woo Jin Hyung; Sung Hoon Noh; Choong Bai Kim
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

8.  Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.

Authors:  Shinji Mine; Takeshi Sano; Naoki Hiki; Kazuhiko Yamada; Toshiyuki Kosuga; Souya Nunobe; Hironobu Shigaki; Toshiharu Yamaguchi
Journal:  Ann Surg Oncol       Date:  2014-02-15       Impact factor: 5.344

9.  Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases.

Authors:  A-Man Xu; Lei Huang; Liang Zhu; Zhi-Jian Wei
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

Review 10.  Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.

Authors:  A-Man Xu; Lei Huang; Wei Liu; Shuang Gao; Wen-Xiu Han; Zhi-Jian Wei
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240
View more
  7 in total

1.  CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.

Authors:  Lei Huang; A-Man Xu; Qiang Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Long-Term Outcomes in Laparoscopic D2 Gastrectomy for Gastric Cancer: a Large Comprehensive Study Proposing Novel Hypotheses.

Authors:  Lei Huang; Hao Liu; Jiang Yu; Tian Lin; Yan-Feng Hu; Tuan-Jie Li; Guo-Xin Li
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

3.  Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort).

Authors:  Jia-Wei Zhang; Lei Huang; A-Man Xu
Journal:  Oncotarget       Date:  2017-02-18

4.  Bone Metastasis From Gastric Adenocarcinoma-What Are the Risk Factors and Associated Survival? A Large Comprehensive Population-Based Cohort Study.

Authors:  Lei Huang; Yajie Zhao; Yan Shi; Weiguo Hu; Jun Zhang
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

5.  Editorial: The use of chemotherapy in treating gastric cancers.

Authors:  Lei Huang; Yan Shi
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

6.  A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort.

Authors:  Lei Huang; Zhi-Jian Wei; Tuan-Jie Li; Yu-Ming Jiang; A-Man Xu
Journal:  Oncotarget       Date:  2017-07-12

7.  Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study.

Authors:  Zhijian Wei; Lei Huang; Xinyue Zhang; Aman Xu
Journal:  BMC Gastroenterol       Date:  2020-10-15       Impact factor: 3.067
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.